Category Archive: Children’s Oncology Group

Jul 28 2017

Psychology in Media Award, Targeted Cancer Drugs, Dermatology App, CHOP ROP Model, Beckwith-Wiedemann Conference

Read on for more exciting headlines from this week, including highlights from our inaugural “Deciphering Beckwith-Wiedemann Syndrome” conference.

Permanent link to this article: http://blog.research.chop.edu/in-the-news-psychology-media-award-targeted-cancer-drugs-dermatology-app-chop-rop-model-beckwith-wiedemann-conference/

Jul 18 2017

Do Researchers Need Standardized Dosing for Infant Anticancer Drug Trials?

Researchers from the Children’s Oncology Group (COG) have developed a new standardized dosing method for anticancer drugs in infants to use across all COG clinical trials. This unified method, based on dose banding and organized into tables for different drugs and dose levels, will address the limitations and variability that researchers can encounter in current methods.

Permanent link to this article: http://blog.research.chop.edu/researchers-need-standardized-dosing-infant-anticancer-drug-trials/

Oct 17 2016

A Conversation With Drs. Bryan Wolf and Peter Adamson on Cancer Moonshot

Every space flight mission requires a carefully planned trajectory, and similarly the national Cancer Moonshot initiative needed a scientific roadmap to reach its ambitions of accelerating the prevention, diagnosis, and treatment of cancer to make a decade of progress in the next five years.

Permanent link to this article: http://blog.research.chop.edu/conversation-drs-bryan-wolf-peter-adamson-cancer-moonshot/

Apr 08 2016

CHOP Research In The News: New Syndrome Named, National Honor for Pediatric Oncologist

Check out the most exciting research news from The Children’s Hospital of Philadelphia this week. From leading a group of international researchers who identified a new syndrome to working on a prestigious panel that will give guidance about ways to advance treatments for children with cancer, CHOP researchers are putting pediatric research in motion.

Permanent link to this article: http://blog.research.chop.edu/chop-research-in-the-news-new-syndrome-named-national-honor-for-pediatric-oncologist/

Feb 12 2016

CHOP Research In The News: Teaching About Human Milk, Teen Depression

Improving exclusive human milk feedings for NICU infants is a major public health issue in India, where Diane Spatz, PhD, RN-BC, FAAN, director of The Children’s Hospital of Philadelphia’s Breastfeeding and Lactation Program, spent two weeks teaching nurses and physicians about human milk and implementation of her 10 Step Model for Human Milk and Breastfeeding in Vulnerable Hospitals.

Permanent link to this article: http://blog.research.chop.edu/chop-research-in-the-news-teaching-about-human-milk-teen-depression/

Feb 05 2016

CHOP Research In the News: Triple-Threat Cancer Gene, Autism and Faces

Cancer genetics and collaboration were big themes in this week’s news featuring research at The Children’s Hospital of Philadelphia. Check out our weekly summary of some of the developments this first week of February.  

Continue reading »

Permanent link to this article: http://blog.research.chop.edu/chop-research-in-the-news-triple-threat-cancer-gene-autism-and-faces/

Feb 02 2016

Scientists Discover a Better ALK Inhibitor to Treat Neuroblastoma

Pediatric cancer researchers at The Children’s Hospital of Philadelphia believe they have succeeded in their search for a powerful next-generation drug for neuroblastoma tumors with mutations in the anaplastic lymphoma kinase (ALK) gene associated with the cancer. Based on their preclinical findings, they are fast-tracking the launch of a clinical trial this year. Usually appearing …

Continue reading »

Permanent link to this article: http://blog.research.chop.edu/scientists-discover-a-better-alk-inhibitor-to-treat-neuroblastoma/

Aug 04 2015

New Ways Needed to Predict, Treat Relapsed Leukemia

Despite advances in T-cell acute lymphoblastic leukemia treatment, between 15 and 20 percent of children who achieve an initial complete remission will relapse. They may need more intensive therapy or alternative approaches, but physicians do not yet have a reliable way of predicting which patients are at high-risk of relapse.

Permanent link to this article: http://blog.research.chop.edu/new-ways-needed-to-predict-treat-relapsed-leukemia/

Jun 30 2015

Researchers Pinpoint Mutations in Relapsed Neuroblastoma

An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy.

Permanent link to this article: http://blog.research.chop.edu/researchers-pinpoint-mutations-in-relapsed-neuroblastoma/

Jun 07 2015

Researchers Help to Improve Young Cancer Survivors’ Quality of Life

Goli Mostoufi-Moab, MD, MSCE, a dual-certified pediatric oncologist and endocrinologist at CHOP, has taken the lead to study endocrinopathies, affecting up to 40 to 60 percent of childhood cancer survivors.

Permanent link to this article: http://blog.research.chop.edu/researchers-help-to-improve-young-cancer-survivors-quality-of-life/

Older posts «